Exclusives

Researchers from Tokyo Univ of Science in Japan have developed a novel, low-cost hydrogel using a component found in seaweed that exhibited ideal pH and moisture conditions for wound recovery with lower adhesion and swelling. Animal testing...

An 82-patient study will evaluate the routine use of NPWT in primary hip and knee arthroplasties. The primary outcome measure is wound-related complications and the estimated study completion date is Dec 10, 2026. clinicaltrials.gov

A 176-patient retrospective study examined electronic records of 50k patients after open surgery. Results showed that 11% of patients developed surgical site infections, of which 15% were inpatient and 85% were in the community after...

FeelTect announced the closing of a ~$1.6MM {€1.5MM) investment from strategic Irish and int'l investors. FeelTect's flagship product, Tight Alright, is a connected-health technology for measuring and remotely monitoring sub-bandage pressure...

MiMedx announced receipt of an FDA Warning Letter for AXIOFILL, which, according to the FDA, does not meet the requirements as a Section 361 product and is subject to enforcement as a Section 351 product. The Company continues to work with...

Intellicure, a leader in wound data technology, has announced leadership changes with David Walker, co-founder and CEO, moving to the role of CFO and COO; Matt Pine was promoted to the position of President and CEO.

Spectral MD has been awarded a new BARDA Project BioShield contract valued at $149MM for its AI-driven DeepView burn wound imaging technology for routine burn care and burn mass casualty incidents. This new contract brings the total potential...

A 190-pt RCT will examine remote use of thermovisual monitoring to reduce the rate of re-ulceration in DFU pts w/ primary outcome of risk reduction of incidence of new DFUs up to 12 mos. Recruitment is ongoing w/ study completion estimated in...